Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03391362 · ClinicalTrials.gov registry record · NA
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
A NA study of Small-cell Lung Cancer and Brain Metastases, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03391362 is a NA study of Small-cell Lung Cancer and Brain Metastases that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 100 participants, below the 231-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03391362, a NA study of Small-cell Lung Cancer and Brain Metastases, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is studying stereotactic radiation (focused/pinpoint radiation that targets each individual tumor but not the surrounding brain) instead of whole-brain radiation (radiation targeting the entire brain) as a possible treatment for patients with small cell lung cancer and 1-10 brain metastases. The intervention involved in this study is: -Stereotactic (focused, pinpoint) radiation
Conditions Studied
Interventions
- RADIATION Stereotactic Radiation
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-23 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03391362
The ClinicalTrials.gov registry entry for NCT03391362 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (57% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Radiation is the first listed.
NCT03391362 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03391362 about?
NCT03391362 is a clinical study titled "Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases". This research study is studying stereotactic radiation (focused/pinpoint radiation that targets each individual tumor but not the surrounding brain) instead of whole-brain radiation (radiation targeting the entire brain) as a possible treatment for patients with small cell lung cancer and 1-10 brain...
What is the current status of trial NCT03391362?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2018-02-23. Estimated completion is 2026-02-01.
What conditions does trial NCT03391362 study?
This clinical trial studies the following conditions: Small-cell Lung Cancer, Brain Metastases.
What interventions are being tested in trial NCT03391362?
The interventions under investigation include: Stereotactic Radiation (RADIATION).
Who is sponsoring clinical trial NCT03391362?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03391362 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Hospital-at-Home for People Receiving Tarlatamab
RECRUITING · NA
-
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
RECRUITING · NA
-
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer
COMPLETED · NA
-
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.